Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
CNS Pharmaceuticals, Inc. (CNSP)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
1 Feb 2024
Evans Carl Anthony
Director
CNS Pharmaceuticals, Inc.
(CNSP)
33,458
+26666%
33,333
$0.30
$9,999.90
BUY
1 Feb 2024
Downs Christopher
Chief Financial Officer, Officer
CNS Pharmaceuticals, Inc.
(CNSP)
103,438
+181%
66,666
$0.30
$19,999.80
BUY
1 Feb 2024
Climaco John M
Chief Executive Officer, Director, Officer
CNS Pharmaceuticals, Inc.
(CNSP)
215,676
+340%
166,666
$0.30
$49,999.80
BUY
1 Feb 2024
Gumulka Jerzy
Director
CNS Pharmaceuticals, Inc.
(CNSP)
43,006
+344%
33,333
$0.30
$9,999.90
BUY
22 Aug 2023
Downs Christopher
Chief Financial Officer, Officer
CNS Pharmaceuticals, Inc.
(CNSP)
36,772
+276%
27,000
$1.27
$34,176.60
BUY
16 Aug 2023
Climaco John M
Chief Executive Officer, Director, Officer
CNS Pharmaceuticals, Inc.
(CNSP)
49,010
+5%
2,750
$1.80
$4,944.50
BUY
19 Apr 2023
Gumulka Jerzy
Director
CNS Pharmaceuticals, Inc.
(CNSP)
9,673
+34%
2,500
$1.70
$4,250.00
BUY
17 Apr 2023
Downs Christopher
Chief Financial Officer, Officer
CNS Pharmaceuticals, Inc.
(CNSP)
9,251
+50%
3,100
$3.20
$9,920.00
BUY
12 Apr 2023
Climaco John M
Chief Executive Officer, Director, Officer
CNS Pharmaceuticals, Inc.
(CNSP)
45,010
+49%
15,000
$0.69
$10,408.50
BUY
10 Apr 2023
Gumulka Jerzy
Director
CNS Pharmaceuticals, Inc.
(CNSP)
7,173
+100%
7,173
$0.74
$5,308.02
SELL
6 Dec 2022
Priebe Waldemar
10% Owner
CNS Pharmaceuticals, Inc.
(CNSP)
156,807
-37%
94,298
$1.41
$133,114.14
BUY
6 Dec 2021
Downs Christopher
Chief Financial Officer, Officer
CNS Pharmaceuticals, Inc.
(CNSP)
151,500
+3%
5,000
$0.94
$4,701.50
BUY
19 Nov 2021
Downs Christopher
Chief Financial Officer, Officer
CNS Pharmaceuticals, Inc.
(CNSP)
146,500
+3%
4,500
$1.15
$5,191.65
BUY
24 Aug 2020
Downs Christopher
Chief Financial Officer, Officer
CNS Pharmaceuticals, Inc.
(CNSP)
142,000
+100%
142,000
$2.04
$289,680.00
Home